Plant-Derived Secondary Metabolites as Potential Mediators Against COVID-19 by MetA-Analysis, Docking, and Molecular Dynamics Methods

Document Type : Original Article

Authors

Department of Cell & Molecular Biology, Faculty of Life Sciences & Biotechnology, Shahid Beheshti University,Tehran, Iran

Abstract

Coronaviruses are viruses that often cause acute complications in the respiratory system with, symptoms similar to those of a cold. Traditions Medicine uses medicinal plants to treat various diseases, including infectious diseases. This research aims to determine the effective antiviral compounds of medicinal plants (Glycyrrhiza glabra, Echinacea purpurea, Panax ginseng, and Cichorium intybus) and the genes involved in their synthesis against coronavirus. In this study, the secondary metabolites were investigated in terms of the inhibition of COVID-19 through meta-analysis. In the database, the interaction of proteins concerning each other and hub genes was obtained from Cytoscape software. To study the ontology of genes from the Enrichr database and then Barsam HeatMap, the expression of the genes was measured relative to each other. As a result of the meta-analysis, 14 genes related to blood coagulation factors and the complement system (immune system) were determined. The compounds of medicinal plants with antiviral and antimicrobial effects were extracted from the PubChem database for docking and then checked by the HeatMap database. As a result of the meta-analysis, 14 genes related to blood clotting factors and the complement system (immune system) were found. The results obtained from the Kegg Pathway server were evaluated, and the two factors coagulation factor X (F10) and coagulation factor II thrombin (F2) as the reactivity of human cells when exposed to the virus and spike protein and main protease as the coronavirus receptor were extracted from the PDB database. Receptor (1A2C, 6lu7, 4Y79, 6VXX)-ligand docking (secondary combinations) was confirmed by the coach-d protein-ligand server. In the end, their validation was done by performing molecular dynamics using Gromax software. According to these results, by reducing the expression of thrombin factor and factor x, it prevents blood clotting, and by inhibiting the spike protein and the main protease of the Coronavirus, it prevents the multiplication of the virus using the antiviral extract of these plants.

Keywords

References

Nuraskin CA, Idroes RM Soraya C, jufri, D. (2019). Activities inhibition methanol extract laban leaf (Vitex pinnata) on the growth of bacteria S. mutans Atcc 31987. IOP Conference Series: Materials Science and Engineering: 523 (1): p. 012008. Doi: 10.1088/1757-899X/523/1/012008.
Hayashi K, Mori M, Matsutani Y, Suzutan T, Ogasawara M, Yoshida I, Hosokawa Keizo, Tsukui A. Azuma, M. (2003). Anti-Influenza Virus Activity of a Red-Fleshed Potato Anthocyanin. Food Science and Technology Research: 9 (3): 242-244. Doi.org/10.3136/fstr.9.242.
Qian Z, Ou X, Góes LG, Osborne C, Castano A, Holmes KV, Dominguez SR. (2015). Identification of the receptor-binding domain of the spike glycoprotein of human betacoronavirus HKU1. Journal of Virology: 89(17):8816-8827. Doi.org/10.1128/jvi.03737-14.
Ren L, Wang YM. Wu ZQ, Xiang ZC, Guo L, Xu T, Jiang YZ, Xiong Y, Li YJ, Li XW, Li H, Fan GH, Gu XY, Xiao Y, Hong GH, Xu JY, Yang F, Wang XM, Wu C, Chen L, Liu YW, Liu B, Yang J, Wang XR, Dong J, Li L. (2020). Identification of a novel coronavirus causing severe pneumonia in humans: a descriptive study. Chinese Medical Journal. 133 (9):1015-1024. Doi: 10.1097/CM9.0000000000000722.
Vaira LA, Salzano G, Deiana G, De Riu G. (2020). Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. Doi: 10.1002/lary.28692.
Recalcati S. (2020). Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology. 34 (5): 212–213.  Doi:10.1111/jdv.16387.
Earlia N, Suhendra R, Amin M, Prakoeswa CRS, Idroes R. (2019). GC/MS analysis of fatty acids on Pliek U oil and its pharmacological study by molecular docking to filaggrin as a drug candidate in atopic dermatitis treatment. The Scientific World Journal. Pp 1-7. Doi: https://doi.org/10.1155/2019/8605743.
Mustafa S, Balkhy H, Gabere M. (2019). Peptide protein interaction studies of antimicrobial peptides targeting Middle East respiratory syndrome coronavirus spike protein: An In Silico Approach. Advances in Bioinformatics. p16. Doi: https://doi.org/10.1155/2019/6815105.
Shakeran Z, Nosrati M, Shakeran Z. (2018). In silico screening of hepatitis C virus NS3/4A protease inhibitor(s) from Cornus officinalis and Syzygium aromaticum. Razi. Journal of Medical Sciences: 25(2): 69-80. Doi: 10.3390/v2081752.
Cheng PW, Ng LT, Chiang LC, Lin CC. (2006). Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clinical and Experimental Pharmacology and Physiology. 33: 612-616. Doi: https://doi.org/10.1111/j.1440-1681.2006.04415.x.
Nuraskin CA, Marlina M, Idroes RM, Soraya C, jufri D. (2020). Identification of secondary metabolite of laban leaf extract (Vitex pinnata L.) from geothermal areas and nongeothermal of agam mountains in Aceh Besar, Aceh province, Indonesia. Rasayan Journal of Chemistry. 13 (1): 18–23. Doi: 10.31788/RJC.2020.1315434.
Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen. T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. (2020). Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications. 11 (1): 1620. Doi: 10.1038/s41467-020-15562-9.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395 (10223): 497-506. Doi: 10.1016/S0140-6736(20)30183-5.
Khwaza V, Oyedeji O, Aderibigbe BA. (2018). Antiviral activities of oleanolic acid and its analogues. Molecules. 23: p 2300. Doi: https://doi.org/10.3390/molecules23092300.
Pratiwi SUT, Lagendijk EL, deWeert S, Idroes R, Hertiani T, Hondel CV. (2015). Effect of Cinnamomum burmannii Nees ex Bl. and Massoia aromatica Becc. essential oils on planktonic growth and biofilm formation of Pseudomonas aeruginosa and Staphylococcus aureus in vitro. International Journal of Applied Research in Natural Products. 8 (2):1-13.
Jensen J, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, Von Mering C. (2009). STRING 8--a global view of proteins and their functional interactions in 630 organisms. Nucleic Acids Research. 37: D412–D416. Doi: https://doi.org/10.1093/nar/gkn760.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research. 13 (11): 2498-2504. Doi: https://doi.org/10.1101/gr.1239303.
Kanehisa M and Goto S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research. 28 (1): 27–30. Doi.org/10.1093/nar/28.1.27.
 Jiahua H, Huanyu T, Yumeng Y, Sheng-You H, Xiao Yi. (2020). Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV). bioRxiv preprint Doi: https://doi.org/10.1101/2020.02.17.952903.
Diao K, Han P, Pang T, Li Y, Yang Z. (2020). HRCT Imaging Features in Representative Imported Cases of 2019 Novel Coronavirus Pneumonia. Precision Clinical Medicine. 3 (1): 9-13. Doi: 10.1093/pcmedi/pbaa004.
Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, Guo D, Fu L, Cui Y, Arledge KC, Chen YH, Zhang L, Wang X. (2013). Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research. 23: 986–993. https://doi.org/10.1038/cr.2013.92.
Balkrishna A, Pokhrel S, Singh J, Varshney A. (2020). Withanone from Withania somnifera may inhibit Novel Coronavirus (COVID-19) entry by disrupting interactions between the viralS protein receptor binding domain and host ACE2 receptor. Virology. 1-26. Doi: https://doi.org/10.2147/DDDT.S292805.
Tallei TE, Tumilaar SG, Niode NJ, Wali F, Kepel  BJ, Idroes R, Effendi Y. (2020). Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study. Scientifica. P. 18. Doi.org/10.1155/2020/6307457.
Benet LZ, Hosey CM, Ursu O, Oprea TI. (2017). BDDCS, the rule of 5, and Drugability. Advanced Drug Delivery Reviews. 1: 101: 89-98. Doi: 10.1016/j.addr.2016.05.007.
Ding Y, Cao Z, Cao L, Ding G, Wang Z, Xiao W. (2017). Antiviral activity of chlorogenic acid against influenza A (H1N1/ H3N2) virus and its inhibition of neuraminidase. Scientific Reports. 7: 45723. Doi: https://doi.org/10.1038/srep45723.
Huang SY, Zou X.  (2010). Advances and challenges in protein -ligand docking. International Journal of Molecular Sciences. 11 (8): 3016 -34. Doi: 10.3390/ijms11083016.
Wadood A, Ahmed N, Shah L, Ahmad A, Hassan H and Shams S. (2013). In -silico drug design: An approach which revolutionarised the drug discovery process. OA Drug Design and Delivery. 1 (1): 3 - 7.
Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. (2012). The sva package for removing batch effects and other unwanted variations in high-throughput experiments. Bioinformatics. 28 (6):882–883. Doi: https://doi.org/10.1093/bioinformatics/bts034.
Lipinski CA. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods. 44 (1): 235 - 49.
Zoete V, Cuendet MA, Grosdidier A. (2011). Michielin Swiss Param: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry. 32 (11): 2359-2368. Doi: https://doi.org/10.1002/jcc.21816.
Leif EP. (2020). COVID-19 and Flavonoids: In Silico Molecular Dynamics Docking to the Active Catalytic Site of SARS-CoV and SARSCoV-2 Main Protease. Doi: 10.13140/RG.2.2.22294. 50246.
Plant, Algae, and Environment
Volume 7, Issue 2
2023
Pages 11197-1212

Files

Share

How to cite

Statistics